title: Reporting sodium channel activity using calcium flux: pharmacological promiscuity of cardiac Nav1.5.
abstract: Voltage-gated sodium (Nav) channels are essential for membrane excitability and represent therapeutic targets for treating human diseases. Recent reports suggest that these channels, e.g., Nav1.3 and Nav1.5, are inhibited by multiple structurally distinctive small molecule drugs. These studies give reason to wonder whether these drugs collectively target a single site or multiple sites in manifesting such pharmacological promiscuity. We thus investigate the pharmacological profile of Nav1.5 through systemic analysis of its sensitivity to diverse compound collections. Here, we report a dual-color fluorescent method that exploits a customized Nav1.5 [calcium permeable Nav channel, subtype 5 (SoCal5)] with engineered-enhanced calcium permeability. SoCal5 retains wild-type (WT) Nav1.5 pharmacological profiles. WT SoCal5 and SoCal5 with the local anesthetics binding site mutated (F1760A) could be expressed in separate cells, each with a different-colored genetically encoded calcium sensor, which allows a simultaneous report of compound activity and site dependence. The pharmacological profile of SoCal5 reveals a hit rate (>50% inhibition) of around 13% at 10 μM, comparable to that of hERG. The channel activity is susceptible to blockage by known drugs and structurally diverse compounds. The broad inhibition profile is highly dependent on the F1760 residue in the inner cavity, which is a residue conserved among all nine subtypes of Nav channels. Both promiscuity and dependence on F1760 seen in Nav1.5 were replicated in Nav1.4. Our evidence of a broad inhibition profile of Nav channels suggests a need to consider off-target effects on Nav channels. The site-dependent promiscuity forms a foundation to better understand Nav channels and compound interactions.
authors.affiliation: The Solomon H. Snyder Department of Neuroscience, High Throughput Biology Center (H.Z., B.Z., F.D., K.X., M.L.); Johns Hopkins Ion Channel Center (H.Z., B.Z., F.D., K.X., M.L.), Johns Hopkins University, Baltimore, Maryland; and GlaxoSmithKline, King of Prussia, Pennsylvania (M.L.).
authors.forename: Hongkang
authors.initials: H
authors.lastname: Zhang
authors.affiliation: The Solomon H. Snyder Department of Neuroscience, High Throughput Biology Center (H.Z., B.Z., F.D., K.X., M.L.); Johns Hopkins Ion Channel Center (H.Z., B.Z., F.D., K.X., M.L.), Johns Hopkins University, Baltimore, Maryland; and GlaxoSmithKline, King of Prussia, Pennsylvania (M.L.).
authors.forename: Beiyan
authors.initials: B
authors.lastname: Zou
authors.affiliation: The Solomon H. Snyder Department of Neuroscience, High Throughput Biology Center (H.Z., B.Z., F.D., K.X., M.L.); Johns Hopkins Ion Channel Center (H.Z., B.Z., F.D., K.X., M.L.), Johns Hopkins University, Baltimore, Maryland; and GlaxoSmithKline, King of Prussia, Pennsylvania (M.L.).
authors.forename: Fang
authors.initials: F
authors.lastname: Du
authors.affiliation: The Solomon H. Snyder Department of Neuroscience, High Throughput Biology Center (H.Z., B.Z., F.D., K.X., M.L.); Johns Hopkins Ion Channel Center (H.Z., B.Z., F.D., K.X., M.L.), Johns Hopkins University, Baltimore, Maryland; and GlaxoSmithKline, King of Prussia, Pennsylvania (M.L.).
authors.forename: Kaiping
authors.initials: K
authors.lastname: Xu
authors.affiliation: The Solomon H. Snyder Department of Neuroscience, High Throughput Biology Center (H.Z., B.Z., F.D., K.X., M.L.); Johns Hopkins Ion Channel Center (H.Z., B.Z., F.D., K.X., M.L.), Johns Hopkins University, Baltimore, Maryland; and GlaxoSmithKline, King of Prussia, Pennsylvania (M.L.). min.x.li@gsk.com.
authors.forename: Min
authors.initials: M
authors.lastname: Li
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000595:Amino Acid Sequence; D002118:Calcium / Q000378:metabolism*; D057809:HEK293 Cells; D006801:Humans; D008969:Molecular Sequence Data; D062554:NAV1.5 Voltage-Gated Sodium Channel / Q000235:genetics* / Q000378:metabolism*; D026941:Sodium Channel Blockers / Q000494:pharmacology*
chemical_list: D062554:NAV1.5 Voltage-Gated Sodium Channel; C568320:SCN5A protein, human; D026941:Sodium Channel Blockers; D002118:Calcium